Psoriasis is one of the most common chronic inflammatory skin diseases, affecting 3% of the
world's population, and approximately one-third of patients with psoriasis will eventually …

Evidence has shown that gut microbiome plays a role in modulating the development of
diseases beyond the gastrointestinal tract, including skin disorders such as psoriasis. The …

Chronic plaque psoriasis is an immune-mediated inflammatory skin disease that is strongly
associated with the clinical features of the metabolic syndrome (MetS), including abdominal …

Objectives To compare the incidence of psoriatic arthritis (PsA) in patients with psoriasis
(PsO) according to different treatments for their skin: topics/no treatment, conventional …

The human microbiome is a wide range of microorganisms residing in and on our body. The
homeostasis between host immune system and the microbial environment allows mutual …

Over the past 10 years, it has become increasingly evident that nonalcoholic fatty liver
disease (NAFLD) is a multisystem disease that affects multiple extra-hepatic organ systems …

Background Among patients in the United States with psoriasis (PsO), limited data exist on
the incidence and prevalence of psoriatic arthritis (PsA) based on disease severity …

Objective An estimated 40–50% of patients with psoriasis (PsO) have psoriatic nail disease,
which is associated with and directly contributes to a greater clinical burden and worse …

Psoriasis and atopic dermatitis are common, chronic inflammatory skin diseases. We
discuss several aspects of these disorders, including: risk factors; incidence and prevalence; …

Obesity is a common cardiovascular risk factor in psoriatic disease. Although the prevalence
of obesity is high, the factors associated with it in patients with psoriatic arthritis (PsA) are …